[ad_1]
Nuveen LLC acquired a new position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 40,047 shares of the company’s stock, valued at approximately $101,000. Nuveen LLC owne
[ad_2]
Source link